Pirnabin

Pirnabin
(IUPAC) ime
	(3,6,6,9-tetrametil-7,8,9,10-tetrahidrobenzo[c]hromen-1-il) acetat
Klinički podaci
Identifikatori
CAS broj	68298-00-0
ATC kod	nije dodeljen
PubChem	50137
UNII	S3FHL03F60
Hemijski podaci
Formula	C19H24O3
Mol. masa	300,391 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C19H24O3/c1-11-6-7-15-14(8-11)18-16(21-13(3)20)9-12(2)10-17(18)22-19(15,4)5/h9-11H,6-8H2,1-5H3 ; Key: AADNQNOXNWEYHS-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Pirnabin (SP-304) je sinthetički ligand kanabinoidnog receptora. Ovo jedinjenje je razvijeno za tretman glaukoma.^[3]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Stig Agurell, ur. The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects. ISBN 9780323141987.

	Portal Medicina
	Portal Hemija